NYKB ์ฝ”๋กœ๋‚˜ ๋ฐ”์ด๋Ÿฌ์Šค ๊ณต๋ถ€๋ฐฉ

๋ถ„์ž ์ง„๋‹จ / ์น˜๋ฃŒ์ œ / ๋ฐฑ์‹  ๊ฐœ๋ฐœ

10. 16. 2020 (FRI) 8:00 PM, EST
Zoom WEBINAR

RSVP

๋ฐ•ํฌ๊ฒฝ Ph.D.

์‹œ์„ ๋ฐ”์ด์˜ค๋จธํ„ฐ๋ฆฌ์–ผ์Šค ๋Œ€ํ‘œ

์„ธ์…˜ 1. ์ฝ”๋กœ๋‚˜ ๋ฐ”์ด๋Ÿฌ์Šค์— ๋Œ€ํ•œ ๋ถ„์ž์ง„๋‹จ์˜ ํ˜„ํ™ฉ๊ณผ ์ „๋ง

The Molecular Diagnosticsโ€™s Innovations in the Post COVID-19

2020๋…„ 9์›” FDA ํ‰๊ฐ€ ๊ธฐ์ค€, ์ „ ์„ธ๊ณ„ 3์œ„ ๊ตญ๋‚ด 1์œ„
์ฝ”๋กœ๋‚˜ ๋ฐ”์ด๋Ÿฌ์Šค ์ง„๋‹จ kit ๊ฐœ๋ฐœ ๊ธฐ์—…, ์‹œ์„ ๋ฐ”์ด์˜ค

[๊ด€๋ จ๊ธฐ์‚ฌ๋งํฌ]

์‹ ๋™ํ˜ Ph.D.

ํ˜„ ์ธ์ฒœ๋Œ€ํ•™๊ต ๊ต์ˆ˜
์ „ ๋…์ผ ๋ง‰์Šคํ”Œ๋ž‘ํฌ ์ƒ๋ฌผ๋ฌผ๋ฆฌํ•™์—ฐ๊ตฌ์†Œ

์„ธ์…˜ 2. ์ฝ”๋กœ๋‚˜ ๋ฐ”์ด๋Ÿฌ์Šค ์น˜๋ฃŒ์ œ ๊ฐœ๋ฐœ์˜ ํ˜„ํ™ฉ๊ณผ ์ „๋ง

Targeting PLpro of SARS-CoV-2 as double-hit therapeutic strategy against COVID-19

2020๋…„ 7์›” ์ฝ”๋กœ๋‚˜๋ฐ”์ด๋Ÿฌ์Šค ์น˜๋ฃŒ์ œ ์—ฐ๊ตฌ ๊ฒฐ๊ณผ
๋„ค์ด์ฒ˜ ๊ฒŒ์žฌํ•œ ํ•œ๊ตญ์ธ ์—ฐ๊ตฌ์ž

[๊ด€๋ จ๊ธฐ์‚ฌ ๋งํฌ]

์†ก๋งŒ๊ธฐ Ph.D.

๊ตญ์ œ๋ฐฑ์‹ ์—ฐ๊ตฌ์†Œ ๊ณผํ•™์‚ฌ๋ฌด์ฒ˜์žฅ

์„ธ์…˜ 3. ์ฝ”๋กœ๋‚˜๋ฐ”์ด๋Ÿฌ์Šค์˜ ๋ฐฑ์‹  ๊ฐœ๋ฐœ ํ˜„ํ™ฉ

COVID-19 Vaccine Development

์ „ ์„ธ๊ณ„ ๋ณด๊ฑด์„ ์œ„ํ•œ ๋ฐฑ์‹  ๊ฐœ๋ฐœ ๊ตญ์ œ๊ธฐ๊ตฌ
๊ตญ์ œ๋ฐฑ์‹ ์—ฐ๊ตฌ์†Œ ๋ฐฑ์‹ ๊ฐœ๋ฐœ ์ „๋ฌธ๊ฐ€

[๊ด€๋ จ๊ธฐ์‚ฌ๋งํฌ]

RSVP